The mammalian nervous system is an extremely complicated network of tissues making targeting of selected biological active compounds to specific portions of the system extremely difficult. The primary difficulty in targeting neurons for treatment with specific compounds has been the fact that no delivery vehicle specific for a given subpopulation of neurons has existed. We intend to use the highly specific binding of the heavy chain of botulinal neurotoxin to motor neurons as a delivery vehicle for multiple copies of pharmaceutical ligands to the cytosol of these neurons. We intend to synthesize molecules capable of delivering a wide variety of biologically active compounds to the cytosol of motor neurons.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43NS038786-01
Application #
2867676
Study Section
Special Emphasis Panel (ZRG1-BDCN-1 (07))
Program Officer
Heemskerk, Jill E
Project Start
1999-09-30
Project End
2000-03-29
Budget Start
1999-09-30
Budget End
2000-03-29
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Metabiologics, Inc.
Department
Type
DUNS #
City
Madison
State
WI
Country
United States
Zip Code
53719